Category: "Neurology"

Epilepsy drug (Gabapentin/Neuronton) linked to opioid misuse

Epilepsy drug (Gabapentin/Neuronton) linked to opioid misuse

A recent study conducted by Duquesne University professor John Tomko has linked high dosages of the epilepsy drug Gabapentin to opioid abuse. Based on the findings of the study, Tomko recommends prescribing and distributing Gabapentin with more scrutiny and oversight. Gabapentin, brand name Neurontin, has been formally approved by the Food and Drug Administration (FDA) […]

Nonepileptic Myoclonus Doesn’t Affect Cognition, But Affects Quality of Life Significantly, Researchers Say

Nonepileptic Myoclonus Doesn’t Affect Cognition, But Affects Quality of Life Significantly, Researchers Say

Nonepileptic myoclonus is a common feature in Angelman adolescents and young adults, and although it does not affect consciousness or cause cognitive consequences, it can affect quality of life significantly, a study shows. The research, “Myoclonus in Angelman Syndrome” and published in Epilepsy & Behavior, was presented recently by Kimberly Parkin, from the Angelman Syndrome […]

Moving Toward Enhanced Regenerative Medicine To Cure Epilepsy

At the border between regenerative medicine and neural engineering lies enhanced regenerative medicine. Using brain tissue modulated by electronic components, EU research has tackled the most common form of epilepsy. Photo© Gabriella Panuccio Temporal lobe epilepsy (TLE) is the most common form of epilepsy and yet, the most unresponsive to treatment. Patients have a typical […]

Early Treatment Failure More Likely With Carbamazepine vs Lamotrigine in Epilepsy

In patients with epilepsy, moderate-quality evidence indicates that treatment failure for any reason related to therapy or adverse events (AEs) occurs significantly earlier with carbamazepine than with lamotrigine, although the results for time to first seizure imply that carbamazepine may be superior to lamotrigine for seizure control. Results of the review were published in the Cochrane Database of Systematic […]

Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines

Treatment of New-Onset Epilepsy: AAN, AES Update Practice Guidelines

The American Academy of Neurology (AAN) and the American Epilepsy Society (AES) have provided new recommended practice guidelines for the management of new-onset and treatment-resistant epilepsy with anti-epileptic drugs (AEDs).1,2 The new guidelines highlight the evidence supporting the use of lamotrigine, vigabatrin, levetiracetam, pregabalin, gabapentin, and zonisamide for reducing the frequency of seizures in new-onset […]

Epilepsy: New findings ‘could change textbooks’

Epilepsy: New findings ‘could change textbooks’

New research finds that two key brain proteins are involved in the neuronal misfiring that characterizes epilepsy. The findings “could potentially change textbooks” on epilepsy, according to the researchers, as well as pave the way for new therapies. The World Health Organization (WHO) estimate that 50 million people worldwide have epilepsy, making it one of […]

RECENT NEWS